XML 20 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ (DEFICIT) EQUITY - USD ($)
$ in Millions
Total
Bausch Health Companies Inc. Shareholders’ Deficit
Common Shares
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Non- controlling Interest
Beginning Balance (in shares) at Dec. 31, 2022     361,900,000        
Beginning Balance at Dec. 31, 2022 $ 260 $ (692) $ 10,391 $ 159 $ (9,186) $ (2,056) $ 952
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     3,100,000        
Common shares issued under share-based compensation plans 0   $ 29 (29)      
Share-based compensation 103 103   103      
Employee withholding taxes related to share-based awards (23) (23)   (23)      
Vesting of B+L equity compensation 0 (20)   (20)     20
Noncontrolling interest distribution (9)           (9)
Net loss (564) (553)     (553)   (11)
Other comprehensive (loss) income (2) 5       5 (7)
Ending Balance (in shares) at Sep. 30, 2023     365,000,000.0        
Ending Balance at Sep. 30, 2023 (235) (1,180) $ 10,420 190 (9,739) (2,051) 945
Beginning Balance (in shares) at Jun. 30, 2023     364,000,000.0        
Beginning Balance at Jun. 30, 2023 271 (663) $ 10,412 188 (9,361) (1,902) 934
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     1,000,000.0        
Common shares issued under share-based compensation plans 0   $ 8 (8)      
Share-based compensation 29 29   29      
Employee withholding taxes related to share-based awards (8) (8)   (8)      
Vesting of B+L equity compensation 0 (11)   (11)     11
Noncontrolling interest distribution (9)           (9)
Net loss (382) (378)     (378)   (4)
Other comprehensive (loss) income (136) (149)       (149) 13
Ending Balance (in shares) at Sep. 30, 2023     365,000,000.0        
Ending Balance at Sep. 30, 2023 $ (235) (1,180) $ 10,420 190 (9,739) (2,051) 945
Beginning Balance (in shares) at Dec. 31, 2023 365,238,917   365,200,000        
Beginning Balance at Dec. 31, 2023 $ (82) (1,022) $ 10,423 214 (9,778) (1,881) 940
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     2,500,000        
Common shares issued under share-based compensation plans 0   $ 66 (66)      
Share-based compensation 107 107   107      
Employee withholding taxes related to share-based awards (23) (23)   (23)      
Vesting of B+L equity compensation 0 (31)   (31)     31
Noncontrolling interest distribution (10)           (10)
Net loss (170) (139)     (139)   (31)
Other comprehensive (loss) income $ (64) (66)       (66) 2
Ending Balance (in shares) at Sep. 30, 2024 367,695,267   367,700,000        
Ending Balance at Sep. 30, 2024 $ (242) (1,174) $ 10,489 201 (9,917) (1,947) 932
Beginning Balance (in shares) at Jun. 30, 2024     367,000,000.0        
Beginning Balance at Jun. 30, 2024 (227) (1,175) $ 10,483 181 (9,832) (2,007) 948
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     700,000        
Common shares issued under share-based compensation plans 0   $ 6 (6)      
Share-based compensation 38 38   38      
Employee withholding taxes related to share-based awards (5) (5)   (5)      
Vesting of B+L equity compensation 0 (7)   (7)     7
Noncontrolling interest distribution (10)           (10)
Net loss (92) (85)     (85)   (7)
Other comprehensive (loss) income $ 54 60       60 (6)
Ending Balance (in shares) at Sep. 30, 2024 367,695,267   367,700,000        
Ending Balance at Sep. 30, 2024 $ (242) $ (1,174) $ 10,489 $ 201 $ (9,917) $ (1,947) $ 932